Fecal microbiota transplantation for prevention of recurrent acute cholangitis. Review of four published cases.

INTRODUCTION

recurrent acute cholangitis (RAC) constitutes a relevant clinical problem that may condition the prognosis of the patient. Chronic suppressive antibiotic therapy can be used for preventive purposes, but it is associated with adverse effects and can select resistant bacterial strains. Fecal microbiota transfer (FMT) has been shown to be effective to prevent recurrent Clostridioides difficile infection and could be a useful strategy in patients with RAC.

OBJECTIVE

to review the experience of the use of FMT in the prevention of episodes of RAC by reviewing published cases. This article is based on previously published cases without presenting new original clinical data.

RESULT: four cases were identified in which FMT significantly reduced RAC episodes. The patients were characterized by lack of efficacy of conventional treatments, had different predisposing factors for RAC and frequent colonization and infection by multidrug-resistant bacteria.

CONCLUSIONS

the four cases presented provide limited but encouraging evidence of the preventive effect of FMT on successive episodes in patients without biliary tract obstruction. Larger and more adequately designed studies will be necessary to deepen the knowledge of this possible preventive strategy.